000518 *ST四环生物
2025/03 - 三个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)-4.375-25.777-14.490-8.389-5.580
总资产报酬率 ROA (%)-2.826-17.909-10.760-6.347-4.287
投入资产回报率 ROIC (%)-3.618-22.132-12.951-7.593-5.180

边际利润分析
销售毛利率 (%)64.38462.68269.76171.03569.418
营业利润率 (%)-33.162-38.747-32.517-20.047-10.103
息税前利润/营业总收入 (%)-38.194-54.869-32.725-19.249-9.536
净利润/营业总收入 (%)-39.136-55.920-34.158-19.723-10.905

收益指标分析
经营活动净收益/利润总额(%)81.42533.03065.80676.61179.812
价值变动净收益/利润总额(%)0.000-0.441-2.1750.4871.507
营业外收支净额/利润总额(%)15.26430.6653.618-1.0281.602

偿债能力分析
流动比率 (X)3.0603.3394.3114.8605.131
速动比率 (X)0.5780.6480.8541.3431.569
资产负债率 (%)31.70129.68422.42119.58919.083
带息债务/全部投入资本 (%)9.6889.5626.0375.2024.463
股东权益/带息债务 (%)853.355865.0561,464.9781,734.0842,034.423
股东权益/负债合计 (%)200.769220.694325.050385.412397.306
利息保障倍数 (X)-40.535-54.078-32.322-32.414-13.019

营运能力分析
应收账款周转天数 (天)132.704120.182129.931146.201130.011
存货周转天数 (天)2,069.4981,821.1282,066.5601,930.9871,475.480